| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Chemomab Therapeutics Ltd. | Executive VP, CFO & COO | American Depositary Shares | 2,000 | $10,054 | $5.03 | 16 Mar 2022 | Direct |
| Chemomab Therapeutics Ltd. | Executive VP, CFO & COO | Option to Purchase American Depositary Shares | 196,875 | 08 Nov 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CMMB | Chemomab Therapeutics Ltd. | 16 Mar 2022 | 3 | $1,637 | 4 | Executive VP, CFO & COO | 21 Jun 2022, 06:01 |
| CMMB | Chemomab Therapeutics Ltd. | 14 Mar 2022 | 6 | $5,045 | 4 | Executive VP, CFO & COO | 21 Mar 2022, 06:02 |
| CMMB | Chemomab Therapeutics Ltd. | 08 Nov 2021 | 0 | $0 | 3 | Executive VP, CFO & COO | 12 Nov 2021, 05:17 |